Characterization of phage AbpL with a terminally redundant genome and its therapeutic potential against drug-resistant <i>Acinetobacter baumannii</i> infections.

Front Cell Infect Microbiol · 2026 · PMC12960631 · PMID 41798749

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A p-value < 0.05 was considered statistically significant, and p-values < 0.01 or lower indicated highly significant differences. 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Characterization of phage AbpL with a terminally redundant genome and its therapeutic potential against drug-resistant &lt;i&gt;Acinetobacter baumannii&lt;/i&gt; infections.

The sentences

Characterization of phage AbpL with a terminally redundant genome and its therapeutic potential against drug-resistant <i>Acinetobacter baumannii</i> infections.